Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.

Related Articles

Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.

Cancer Treat Rev. 2017 Dec 06;63:61-70

Authors: Xiao X, Garbutt CC, Hornicek F, Guo Z, Duan Z

Abstract
Chromosomal translocations and fusion genes are very common in human cancer especially in subtypes of sarcomas, such as rhabdomyosarcoma, Ewing’s sarcoma, synovial sarcoma and liposarcoma. The discovery of novel chromosomal translocations and fusion genes in different tumors are due to the advancement of next-generation sequencing (NGS) technologies such as whole genome sequencing. Recently, many novel chromosomal translocations and gene fusions have been identified in different types of sarcoma through NGS approaches. In addition to previously known sarcoma fusion genes, these novel specific fusion genes and associated molecular events represent important targets for novel therapeutic approaches in the treatment of sarcomas. This review focuses on recent advances in chromosomal translocations and fusion genes in sarcomas and their potential therapeutic applications in the treatment of sarcomas.

PMID: 29247978 [PubMed – as supplied by publisher]

Be the first to comment

Leave a Reply

Your email address will not be published.


*